Viridian Therapeutics Dividends
| VRDN Stock | USD 15.92 0.11 0.70% |
At this time, Viridian Therapeutics' Dividends Paid is very stable compared to the past year. As of the 17th of March 2025, Dividend Yield is likely to grow to 0, while Dividend Payout Ratio is likely to drop (0.16). Viridian Therapeutics' past performance could be the main factor of why investors trade Viridian Therapeutics stock today. Investors should clearly understand every aspect of the Viridian Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Viridian Therapeutics' dividend schedule and payout information. Viridian Therapeutics dividends can also provide a clue to the current valuation of Viridian Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 16.7 M | 17.5 M | |
| Dividend Payout Ratio | (0.15) | (0.16) | |
| Dividend Paid And Capex Coverage Ratio | (454.64) | (477.37) |
Viridian |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Viridian Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
Viridian Therapeutics Dividends Paid Over Time
Today, most investors in Viridian Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Viridian Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Viridian Therapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Viridian Therapeutics Historical Dividend Yield Growth
A solid dividend growth pattern of Viridian Therapeutics could indicate future dividend growth is likely, which can signal long-term profitability for Viridian Therapeutics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Viridian Therapeutics dividend as a percentage of Viridian Therapeutics stock price. Viridian Therapeutics dividend yield is a measure of Viridian Therapeutics stock productivity, which can be interpreted as interest rate earned on an Viridian Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.